AbbVie's (ABBV) Q2 earnings surpass estimates with revenues also marginally beating the same. Sales of its lead marketed drug, Humira, rise year over year.
Synergies from Recall Holdings acquisition, transformation initiatives and continued strong performance at its storage rental business drove Iron Mountain's (IRM) second-quarter 2017 results.
Acorda's (ACOR) dismal performance in Q2 significantly misses earnings expectations. However, the company's revenues met estimates on the back of strong Ampyra sales.
Daily Press Briefing: Maldives, Central African Republic, Syria, Venezuela, Honduras, Vietnam, Hepatitis, Marlene Briefing by Farhan Haq, Deputy Spokesperson for the Secretary-General. Highlights: -MALDIVES: SECRETARY-GENERAL VOICES CONCERN OVER EROSION OF DEMOCRATIC NORMS - SITUATION IN CENTRAL AFRICAN REPUBLIC NEARING ‘TIPPING POINT,’ U.N. PEACEKEEPING CHIEF WARNS - U.N. SUPPLIES REACH SYRIA’S BESIEGED EASTERN GHOUTA - AHEAD OF SUNDAY ELECTIONS, U.N. HUMAN RIGHTS VOICES CONCERN OVER RISK OF FURTHER VIOLENCE IN VENEZUELA - SENIOR U.N. HUMAN RIGHTS OFFICIAL WRAPS UP HONDURAS VISIT - VIETNAM: U.N. AGENCY DISQUIETED BY STEPPED UP CRACKDOWN ON HUMAN RIGHTS DEFENDERS -ON WORLD DAY, WORLD HEALTH ORGANIZATION URGES COUNTRIES TO TURN COMMITMENTS INTO ACTION TO ELIMINATE HEPATITIS More: https://www.un.org/sg/en/content/ossg/noon-briefing-highlight?date%5Bvalue%5D%5Bdate%5D=28+July+2017
(SGS Subscription required) • Nonsense GDP Reporting Intensified • "Advance" Estimate of Second-Quarter 2017 Real GDP Came in at a Near-Consensus 2.57% versus a Downwardly-Revised 1.24% First-Quarter Estimate • Annual Benchmark Revisions Were Minimal in Aggregate, Showing Weaker GDP Growth in 2016 and Somewhat Stronger Growth in 2014 into 2015 • Gross Domestic Income (GDI) and Gross National Product (GNP) Growth Rates Also Slowed in 2016 Revisions
Seattle Genetics (SGEN) incurred narrower-than-expected loss in Q2 and provided an encouraging guidance for Adcetris.
AstraZeneca PLC (AZN) reported second-quarter 2017 core earnings of 87 cents per ADS, which beat the Zacks Consensus Estimate of 41 cents. Failure in lung cancer study on Imfinzi however pulled the stock down.
United Therapeutics Corporation (UTHR) incurred a loss in Q2. However, stronger sales across the PAH franchise pulled up the top line in the quarter.
Mohawk Industries (MHK) revenues in the quarter increased on higher sales at the Flooring North America and Rest of the World segments.
Pinnacle Foods Inc. (PF) reported mixed second-quarter 2017 results, wherein though the bottom line outpaced the Zacks Consensus Estimate, top line missed the same.
Mettler-Toledo's (MTD) second-quarter earnings were driven by strong growth from Field Turbo investments, marketing initiatives, Spinnaker sales and new product launches.
Deckers (DECK) is focused on expanding brand assortments, introducing more innovative line of products and optimizing omnichannel distribution.
Microsemi's (MSCC) third-quarter earnings benefited from improving revenue mix, operational efficiency and strong growth from the data center end-market.
Western Digital (WDC) reported solid fourth-quarter results based on strong demand for both hard drive and NAND-based products from all customer categories.
Columbia Sportswear (COLM) posted narrower-than-expected loss in the second quarter of 2017. Increased sales from its SOREL brand and Europe-direct business helped the company reduce its losses.
ImmunoGen (IMGN) reports second-quarter results beating both earnings and sales estimates.
KB Home (KBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
(SGS Subscription required) • Amidst a Faltering Economy, Political Discord Perils the Dollar and Intensifies Risk of Major Market Turmoil • Freight Index Continued in Low-Level Non-Expansion, Down 11.7% (-11.7%) from Its Pre-Recession Peak • June Gain in and May Upside Revisions to New Orders Reflected Surges in the Irregularly-Unstable Monthly Reporting of Commercial Aircraft Orders, Which Were Up by 131.2% in June and Revised Higher by 11.7% in May • 6.5% Gain in June New Orders Was Just 0.2%, Net of Commercial Aircraft • Net of Commercial Aircraft and Inflation, Orders Were Down 10.0% (-10.0%) from Their Pre-Recession Peak • Consumer Related: Motor Vehicle Orders and Shipments Declined in June • Decimated Second-Quarter 2017 Home Sales and Related Construction: Quarterly Contractions in New-Home Sales (-12.3%), Existing-Home Sales (-3.7%), Building Permits (-13.0%), Housing Starts (-21.9%), Single-Unit (-7.0%), Multiple-Unit (-47.3%) • Monthly Existing-Home Sales Declined in June, Small Gain in New-Home Sales Was Unchanged Net of Revisions • June Existing-Home Sales Were Down by 24.1% (-24.1%) and New-Home Sales Were Down by 56.1% (-56.1%) from Pre-Recession Peaks
Daily Press Briefing: Jerusalem, Syria, Mali, Democratic Republic of the Congo, ECOSOC. Briefing by Farhan Haq, Deputy Spokesperson for the Secretary-General. HIGHLIGHTS --------------------------- - ECRETARY-GENERAL VOICES HOPE FOR CONTINUED DIALOGUE IN WAKE OF CRISIS IN JERUSALEM’S OLD CITY - DESPITE DIP IN VIOLENCE, CIVILIANS CONTINUE TO FACE DIFFICULTIES IN SYRIA, SENIOR U.N. RELIEF OFFICIAL TELLS SECURITY COUNCIL - SECURITY COUNCIL EXTENDS MANDATE OF U.N. MISSION IN CYPRUS - U.N. PEACEKEEPING CHIEF SADDENED BY DEADLY CRASH OF U.N. HELICOPTER IN NORTHERN MALI - D.R. CONGO: LEADER OF ARMED GROUP SURRENDERS TO U.N. MISSION - U.N. ECONOMIC AND SOCIAL COUNCIL ELECTS NEW BUREAU Full Highlights: https://www.un.org/sg/en/content/ossg/noon-briefing-highlight?date%5Bvalue%5D%5Bdate%5D=27+July+2017
Alexion Pharmaceuticals, Inc. (ALXN) exceeded both earnings and revenue estimates in Q2 and also raised its 2017 guidance.